An Updated Portrait of Pathogenesis, Molecular Markers and Signaling Pathways of Hepatocellular Carcinoma

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|23|16|2356-2365

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.16, 2017-06, pp. : 2356-2365

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mitochondrial Signaling and Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Implications

By  

Current Pharmaceutical Design, Vol. 22, Iss. 18, 2016-05 ,pp. : 2689-2696

Bentham Science Publishers

Access to resources Recommend Favorite

The Inducible Effect of LBP on Maturation of Dendritic Cells and the Related Immune Signaling Pathways in Hepatocellular Carcinoma (HCC)

By  

Current Drug Delivery, Vol. 9, Iss. 4, 2012-07 ,pp. : 414-420

Bentham Science Publishers

Access to resources Recommend Favorite

Epigenetic Deregulation of MicroRNAs: New Opportunities to Target Oncogenic Signaling Pathways in Hepatocellular Carcinoma

By  

Current Pharmaceutical Design, Vol. 19, Iss. 7, 2013-02 ,pp. : 1192-1200

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Signalling Pathways in Hepatocellular Carcinoma

By  

Current Pharmaceutical Design, Vol. 23, Iss. 1, 2017-02 ,pp. : 170-175

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of Molecular Signaling in Huh-7 Cells by AM3: A Novel Chemotherapeutic Agent for Hepatocellular Carcinoma

By  

Medicinal Chemistry, Vol. 13, Iss. 1, 2016-12 ,pp. : 49-56

Bentham Science Publishers

Access to resources Recommend Favorite